Login:
 
Savill P. Statins underused for primary prevention in older patients. Practitioner 2012;256 (1754):5

Statins underused for primary prevention in older patients

19 Sep 2012Pais-up subscribers

'A treatment-risk paradox where patients become less likely to receive appropriate treatment with advancing age has been observed in the secondary prevention of cardiovascular disease (CVD). This is particularly apparent for cholesterol-lowering treatment with one study showing the likelihood of statin treatment was 6% lower with each year increase in age. However, it is not clear if such a paradox exists in primary prevention and a recent UK study published in the BMJ addresses this issue...'

Paid-up subscribersThis article can be accessed only if you are a paid-up subscriber to The Practitioner.

To view current online and print subscription rates, and to contact the subscription department, click Subscribe today .

To buy this article (£25+tax) copy the article citation above and click Buy article